National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES

1967 No.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1967.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1967.

Dated this twenty-third day of November, 1967.

CASEY

Governor-General.

By His Excellency’s Command,

(SGD.) A. J. FORBES

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations

Commencement.

1. These Regulations shall come into operation on the first day of December, 1967.

Drugs, &c., that are not pharmaceutical benefits.

2. Regulation 10 of the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by omitting the words “ first column ” (wherever occurring) and inserting in their stead the words “ second column ”; and
(b) by omitting from sub-regulation (3.) the words “ second column ” and inserting in their stead the words “ third column ”.

First, Second, Third, Fourth, and Fifth Schedules.

3. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE

Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in Pharmaceutical Benefits

1.	Acetomenaphthone	15.	Anaesthetic Ether
2.	Acetomenaphthone Tablets	16.	Antazoline Hydrochloride
3.	Acetrizoic Acid	17.	Antimony Potassium Tartrate
4.	Alcohol (95%)	18.	Antimony Potassium Tartrate Injection
5.	Alcohol Dehydrated	19.	Antimony Sodium Tartrate
6.	Alcohols Dilute	20.	Antimony Sodium Tartrate Injection
7.	Almond Oil	21.	Apomorphine Hydrochloride
8.	Aluminium Hydroxide Tablets	22.	Apomorphine Injection
9.	Amethocaine Hydrochloride	23.	Bacillus Calmette-Guèrin Vaccine
10.	Amitriptyline Hydrochloride	24.	Barium Sulphate
11.	Amitriptyline Injection	25.	Belladonna Herb
12.	Amodiaquine Hydrochloride	26.	Belladonna Herb, Powdered
13.	Amphetamine Sulphate	27.	Bemegride
14.	Amylobarbitone Sodium Tablets	28.	Benzhexol Hydrochloride

* Notified In the Commonwealth Gazette on 1967.

Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67 and 116.

14914/67—Price 30c 10/13.11.1967

First Schedule—continued

29.	Benztropine Methanesulphonate	98.	Dexamethasone
30.	Betamethasone	99.	Dexamethasone Acetate
31.	Betamethasone Sodium Phosphate Tablets	100.	Dexamphetamine Sulphate
31.	Betamethasone Sodium Phosphate Tablets	101.	Dextran 110 Injection
32.	Bisacodyl	102.	Dextromethorphan Hydrobromide
33.	Bisacodyl Suppositories	103.	Dextromethorphan Tablets
34.	Bisacodyl Tablets	104.	Dextropropoxyphene Capsules
35.	Busulphan	105.	Dextropropoxyphene Hydrochloride
36.	Butobarbitone	106.	Diamorphine Hydrochloride
37.	Butylated Hydroxyanisole	107.	Diamorphine Injection
38.	Butylated Hydroxytoluene Calciferol Solution	108.	Dibromopropamidine Isethionate
39.	Butylated Hydroxytoluene Calciferol Solution	109.	Dichloralphenazone
40.	Calcium Cyclamate	110.	Dichlorophen
41.	Caramiphen Hydrochloride	111.	Dichlorphenamide
42.	Caramiphen Tablets	112.	Diethazine Hydrochloride
43.	Caraway	113.	Diethylcarbamazine Citrate
44.	Carbimazole	114.	Digitalis Leaf
45.	Carbon Dioxide	115.	Digitalis Prepared
46.	Carbromal Tablets	116.	Digitoxin
47.	Cardamom Fruit	117.	Diloxanide Furoate
48.	Cascara	118.	Dimenhydrinate
49.	Cascara Dry Extract	119.	Dimenhydrinate Injection
50.	Catgut, Sterilised, Surgical	120.	Dimenhydrinate Tablets
51.	Cellulose, Oxidised	121.	Dimercaprol
52.	Cetylpyridinium Chloride	122.	Dimethisterone
53.	Chloral Betaine	123.	Dimethisterone Tablets
54.	Chlorambucil	124.	Diodone Injection
55.	Chlordiazepoxide Capsules	125.	Diphtheria and Pertussis Vaccine
56.	Chlordiazepoxide Hydrochloride	126.	Diphtheria, Tetanus and Poliomyelitis Vaccine
57.	Cloroquine Phosphate	126.	Diphtheria, Tetanus and Poliomyelitis Vaccine
58.	Chloroquine Phosphate Injection	127.	Dipipanone Hydrochloride
59.	Chloroquine Sulphate	128.	Dipipanone Injection
60.	Chlorothiazide	129.	Dodecyl Gallate
61.	Chlorphenesin	130.	Domiphen Bromide
62.	Chlorproguanil Hydrochloride	131.	Edrophonium Chloride
63.	Chlorproguanil Tablets	132.	Emetine and Bismuth Iodide
64.	Chlorpropamide	133.	Emetine Hydrochloride
65.	Cholera Vaccine	134.	Erythromycin
66.	Choline Theophyllinate	135.	Ethinyloestradiol
67.	Choline Theophyllinate Tablets	136.	Ethisterone
68.	Chorionic Gonadotrophin	137.	Ethopropazine Hydrochloride
69.	Chorionic Gonadotrophin Injection	138.	Ethotoin
70.	Cinchocaine Hydrochloride	139.	Ethyl Chloride
71.	Cinnamon	140.	Ethyl Oleate.
72.	Citric Acid, Anhydrous	141.	Ethylenediamine Hydrate
73.	Cochineal	142.	Eugenol
74.	Codeine Compound Tablets	143.	Ferric Citrate (59 Fe) Injection
75.	Codeine Compound Soluble Tablets	144.	Fludrocortisone Acetate
76.	Colchicine	145.	Fluocinolone Acetonide
77.	Colchicum Corm	146.	Fluoxymesterone
78.	Colchicum Liquid Extract	147.	Gallamine Triethiodide
79.	Colistin Sulphate	148.	Gallamine Injection
80.	Colistin Tablets	149.	Gelatin Sponge, Absorbable
81.	Coriander	150.	Gentian
82.	Corticotrophin	151.	Ginger
83.	Cresol and Soap Solution	152.	Gold (198 Au) Injection
84.	Cresol	153.	Griseofulvin
85.	Crotamiton	154.	Halothane
86.	Cyanocobalamin	155.	Helium
87.	Cyanocobalamin (57 Co)	156.	Heparin
88.	Cyanocobalamin (58 Co)	157.	Hexamethonium Tartrate
89.	Cyclamic Acid	158.	Hexamethonium Tartrate Injection
90.	Cyclizine Tablets	159.	Hexylresorcinol
91.	Cyclobarbitone Calcium	160.	Histamine Acid Phosphate
92.	Cyclomethycaine Sulphate	161.	Histamine Acid Phosphate Injection
93.	Cyclopropane	162.	Human Blood, Whole
94.	Dapsone	163.	Human Red Blood, Corpuscles, Concentrated
95.	Deoxycortone Trimethylacetate		Human Red Blood, Corpuscles, Concentrated
96.	Dequalinium Acetate	164.	Human Fibrin Foam
97.	Dequalinium Chloride	165.	Human Fibrinogen

First Schedule—continued

166.	Human Gamma Globulin	234.	Methadone Hydrochloride
167.	Human Gamma Globulin Injection	235.	Methandienone
168.	Human Plasma, Dried	236.	Methohexitone Injection
169.	Human Serum, Dried	237.	Methoin
170.	Human Thrombin	238.	Methyl Hydroxybenzoate
171.	Hydrallazine Hydrochloride	239.	Methylamphetamine Hydrochloride
172.	Hydrallazine Tablets	240.	Methyldopa
173.	Hydrocortisone Ointment	241.	Methylergometrine Maleate
174.	Hydrocortisone Acetate Ointment	242.	Methylihiouracil
175.	Hydrocortisone Hydrogen Succinate	243.	Methylihiouracil Tablets
176.	Hydrocortisone Sodium Succinate	244.	Methyprylone
177.	Hydroflumethiazide	245.	Methyprylone Tablets
178.	Hydrogen Peroxide Solution, Strong	246.	Metronidazole
179.	Hydrocobalamin	247.	Nalorphine Hydrobromide
180.	Hydroxychloroquine Sulphate	248.	Nandrolone Phenylpropionate
181.	Hyoscine Injection	249.	Naphazoline Hydrochloride
182.	Hyoscine Hydrobromide	250.	Neostigmine Bromide
183.	Hyoscyamus	251.	Nialamide
184.	Hyoscyamus Dry Extract	252.	Nialamide Tablets
185.	Imipramine Hydrochloride	253.	Nicotinic Acid
186.	Indigo Carmine	254.	Nikethamide
187.	Influenza Vaccine	255.	Nikethamide Injection
188.	Iodinated (181 I) Human Serum Albumin	256.	Nitrous Oxide
Injection	257.	Norethandrolone
189.	Iodipamide Methylglucamine Injection	258.	Norethandrolone Tablets
190.	Iodised Oil Fluid Injection	259.	Norethisterone
191.	Iodised Oil Viscous Injection	260.	Norethisterone Tablets
192.	Iopanoic Acid	261.	Noscapine
193.	Iopanoic Acid Tablets	262.	Novobiocin Calcium
194.	Iophendylate Injection	263.	Novobiocin Sodium
195.	Iothalmic Acid	264.	Nux Vomica
196.	Ipecacuanha, Prepared	265.	Octyl Gallate
197.	Ipecacuanha and Opium Tablets	266.	Oestradiol Benzoate
198.	Isoniazid	267.	Opium
199.	Isopropyl Alcohol	268.	Opium, Powdered
200.	Lead Acetate	269.	Orange Peel, Dried Bitter
201.	Lead Monoxide	270.	Orange Peel, Fresh Bitter
202.	Lemon Peel, Dried	271.	Oxygen
203.	Levallorphan Injection	272.	Oxyphencyclamine Hydrochloride
204.	Levorphanol Tartrate	273.	Oxytetracycline Dihydrate
205.	Lignocaine Hydrochloride	274.	Paramethadione
206.	Lignocaine and Adrenaline Injection	275.	Paromomycin Capsules
207.	Lignocaine Hydrochloride Injection	276.	Paromomycin Sulphate
208.	Linseed Oil	277.	Pempidine Tartrate
209.	Liothyronine Sodium	278.	Pentamidine Isethionate
210.	Liquorice	279.	Pentamidine Injection
211.	Lucanthone Hydrochloride	280.	Pentolinium Tartrate Tablets
212.	Lucanthone Tablets	281.	Perphenazine
213.	Magnesium Stearate	282.	Perphenazine Tablets
214.	Maize Oil	283.	Pethidine Tablets
215.	Male Fern	284.	Phanquone
216.	Maleic Acid	285.	Phanquone Tablets
217.	Measles Vaccine (Inactivated)	286.	Phenacetin
218.	Measles Vaccine (Live Attenuated)	287.	Phenelzine Sulphate
219.	Mecamylanrine Hydrochloride	288.	Phenelzine Tablets
220.	Meglumine Iothalamate Injection	289.	Phenglutarimide Hydrochloride
221.	Melarsoprol	290.	Phenglutarimide Tablets
222.	Melarsoprol Injection	291.	Phenindamine Tartrate
223.	Menaphthone	292.	Phenindione
224.	Menaphthone Sodium Bisulphite Injection Menaphthone Sodium Bisulphite	293.	Phenmetrazjne Hydrochloride
225.		294.	Phenmetrazine Tablets
225.		295,	Phenolphthalein Tablets
226.	Mepacrine Hydrochloride	296.	Phenolsulphonphthalein
727.	Mephentermine Sulphate	297.	Phenoxybenznmine Hydrochloride
228.	Mephentermine Tablets	298.	Phenoxymethylpenicillin
229.	Meprobamate	299.	Phentolamine Hydrochloride
230.	Meprobamate Tablets	300.	Phentolamine Tablets
231.	Mercaptopurine	301.	Phentolamine Methanesulphonate
232.	Mersalyl Acid	302.	Phentolamine Injection
233.	Metaraminol Tartrate	303.	Phytomenadione

First Schedule—continued

304.	Phytomenadione Capsules	372.	Sodium Stibogluconate
305.	Phytomenadione Tablets	373.	Sodium Stibogluconate Injection
306.	Picrotoxin	374.	Solapsone
307.	Picrotoxin Injection	375.	Solapsone Tablets
308.	Piperazine Citrate	376.	Spironolactone
309.	Piperocaine Hydrochloride	377.	Staphylococcus Antitoxin
310.	Poldine Methylsulphate	378.	Stibophen
311.	Poldine Tablets	379.	Stibophen Injection
312.	Poliomyelitis Vaccine (Inactivated)	380.	Stramonium
313.	Poliomyelitis Vaccine (Oral)	381.	Sulphadimethoxine
314.	Potassium Chloride Injection	382.	Sulphadimidine Sodium
315.	Potassium Perchlorate	383.	Sulphamethizole
316.	Prednisolone Sodium Phosphate Injection	384.	Sulphamethoxydiazine
316.	Prednisolone Sodium Phosphate Injection	385.	Sulphamethoxypyridazine
317.	Prednisone	386.	Sulphapyridine
318.	Prednisone Acetate	387.	Sulphasomidine
319.	Primaquine Phosphate	388.	Sulphasomidine Tablets
320.	Probenecid	389.	Sulphinpyrazone
321.	Procaine and Adrenaline Injection	390.	Sulphobromophthalein Sodium
322.	Prochlorperazine Maleate	391.	Suramin
323.	Prochlorperazine Methanesulphonate	392.	Suramin Injection
324.	Prochlorperazine Tablets	393.	Suxamethonium Chloride
325.	Procyclidine Hydrochloride	394.	Testosterone
326.	Progesterone	395.	Testosterone Phenylpropionate
327.	Proguanil Hydrochloride	396.	Testosterone Phenylpropionate Injection
328.	Promazine Hydrochloride	397.	Testosterone Propionate
329.	Promazine Injection	398.	Tetanus and Pertussis Vaccine
330.	Promazine Tablets	399.	Tetanus Vaccine (Alum Precipitated)
331.	Promethazine Theoclate	400.	Tetanus Vaccine (Purified Toxoid Aluminium Hydroxide)
332.	Promethazine Theoclate Tablets		Tetanus Vaccine (Purified Toxoid Aluminium Hydroxide)
333.	Pronethalol Hydrochloride	401.	Tetanus Vaccine (Simple Solution)
334.	Pronethalol Injection	402.	Tetrachloroethylene
335.	Pronethalol Tablets	403.	Tetrachloroethylene Capsules
336.	Propyl Gallate	404.	Thiambutosine
337.	Propyl Hydroxybenzoate	405.	Thiomersal
338.	Propyliodone	406.	Thiopentone Sodium
339.	Propyliodone Injection	407.	Thiopentone Injection
340.	Propyliodone Oily Injection	408.	Thioridazine Hydrochloride
341.	Propylthiouracil	409.	Thyroid
342.	Pyridostigmine Bromide	410.	Thyroxine Sodium
343.	Pyrimethamine	411.	Tolazoline Hydrochloride
344.	Pyroxylin	412.	Tolbutamide
345.	Quillaia	413.	Tranylcypromine Sulphate
346.	Rabies Antiserum	414.	Tranylcypromine Tablets
347.	Rabies Vaccine	415.	Trichloroethylene
348.	Santonin	416.	Triclofos Sodium
349.	Senna Leaf	417.	Triclofos Tablets
350.	Sesame Oil	418.	Tricyclamol Chloride
351.	Soda Lime	419.	Tripelennamine Hydrochloride
352.	Sodium Acetrizoate Injection	420.	Tryparsamide
353.	Sodium Anoxynaphthonate	421.	Tryparsamide Injection
354.	Sodium Antimonylgluconate	422.	Tuberculin, Old
355.	Sodium Antimonylgluconate Injection	423.	Tuberculin Purified Protein Derivative
356.	Sodium Aurothiomalate	424.	Tubocurarine Chloride
357.	Sodium Bicarbonate Compound Tablets	425.	Tubocurarine Injection
358.	Sodium Bicarbonate Injection	426.	Typhoid-Paratyphoid A and B and Cholera Vaccine
359.	Sodium Calciumedetate		Typhoid-Paratyphoid A and B and Cholera Vaccine
360.	Sodium Chromate (51 Cr) Solution	427.	Typhoid-Paratyphoid A and B and Tetanus Vaccine
361.	Sodium Citrate Tablets		Typhoid-Paratyphoid A and B and Tetanus Vaccine
362,	Sodium Cyclamate	428.	Typhoid-Paratyphoid A, B and C Vaccine
363.	Sodium Diatrizoate		Typhoid-Paratyphoid A, B and C Vaccine
364.	Sodium Diatrizoate Injection	429.	Undecenoic Acid
365.	Sodium Fluoride	430.	Vancomycin Hydrochloride
366.	Sodium Fusidate Capsules	431.	Vancomycin Injection
367.	Sodium Iodide (131 I) Injection	432.	Vinyl Ether
368.	Sodium Iodide (131 I) Solution	433.	Vitamin A Ester Concentrate
369.	Sodium Iothalamate Injection	434.	Yellow Fever Vaccine
370.	Sodium Lauryl Sulphate	435.	Zinc Undecenoate
371.	Sodium Phosphate (32 P) Injection	436.	Zinc Undecenoate Ointment

SECOND SCHEDULE

Regulation 10 (3.).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
1	Acetylcysteine.............................	—
2	Acrylic Resin...............................	—
3	Aluminium Powder, B.P.C............	Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P.
4	Amino Acids...............................	Amino Acids with Sorbitol Amino Acids with Sorbitol and Ethanol
5	Amphotericin B............................	Tetracycline with a buffering agent and Amphotericin B.
6	Aneurine Hydrochloride, B.P........	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
7	Antazoline Sulphate.....................	Antazoline Sulphate with Naphazoline Nitrate B.P.
8	Ascorbic Acid, B.P.......................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
9	Attapulgite...................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
10	Bacitracin, B.P.............................	Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
11	Betamethasone Acetate.................	Betamethasone Acetate with Betamethasone Alcohol
12	Betamethasone Alcohol................	Betamethasone Alcohol with Betamethasone Acetate
13	Betamethasone Sodium Phosphate, B.P.................................................	—
14	Betamethasone Phosphate.............	—
15	Brompheniramine Maleate............	—
16	Calciferol....................................	—
17	Carbachol, B.P.............................	—
18	Carbinoxamine Maleate................	—
19	Carbromal, B.P............................	Carbromal B.P., with Pentobarbitone Sodium B.P.
20	Cetrimide.....................................	Cetrimide with Terric and Spearmint Oil
21	Chloramine, B.P.C.......................
22	Chloramphenicol, B.P...................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
23	Chlorhexidine Gluconate..............	—
24	Chlorpheniramine Maleate, B.P.....	—
25	Chlorpromazine Hydrochloride, B.P.................................................	—
26	Chlortetracycline Hydrochloride, B.P.................................................	—
27	Clemizole Tannate.......................	—
28	Cortisone Acetate, B.P..................	—
29	Cymogran....................................	—
30	Cyproheptadine Hydrochloride B.P.	—
31	Cyclizinc Hydrochloride, B.P........	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
32	Demecarium Bromide..................	—
33	Demethylchlortetracycline Hydrochloride, B.P...................	Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
34	Dexchlorpheniramine Maleate......	—
35	Dextran.......................................	Dextran with Dextrose B.P. Dextran in Normal Saline
36	Dicyclomine Hydrochloride, B.P.	—
37	Dienoestrol, B.P...........................	—
38	Digoxin, B.P................................	—
39	Dihydrostreptomycin Sulphate, B.P. 1958........................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P. Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel
40	Dihydrotachysterol.......................	—
41	Dimethicone................................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
42	Diphenhydramine Hydrochloride, B.P.................................................	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
43	Diphenylpyraline Hydrochloride	—
44	Diphtheria Vaccine, B.P...............	Diphtheria Tetanus Vaccine B.P. Purified Toxoid (Aluminium Phosphate Adsorbed) B.P. Diphtheria Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P.
45	Dyflos, B.P.C...............................	—
46	Ecothiopate Iodide.......................	—
47	Entsufon......................................	Hexachlorophane B.P. with Entsufon
48	Ergometrine Malcate....................	Oxytocin with Ergometrine Maleate
49	Ergotamine Tartrate, B.P..............	Ergotamine Tartrate B.P. with Caffeine B.P. Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P. Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P. Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
50	Erythromycin Oral Suspensions and Syrups......................................	—
51	Erythromycin Paediatric Drops.....	—
52	Ethosuximide...............................	—
53	Ferric Hydroxide..........................	—
54	Ferrous Aminoacetosulphate.........	—
55	Ferrous Succinate.........................	—
56	Framycetin Sulphate.....................	—
57	Fusidic Acid (Diethanolamine Salt)	—
58	Galactomin, Formula No. 11.........	—
59	Galactomin, Formula No. 19.........	—
60	Glucose Indicator.........................	—
61	Glyceryl Guiaiacolate...................	Theophylline with Glyceryl Guiaiacolate
62	Gramicidin..................................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin Gramacidin with Neomycin Sulphate B.P., Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate B.P.
63	Hexachlorophane, B.P..................	Hexachlorophane B.P. with Entsufon Hexachlorophane B.P. with Terric Hexachlorophane B.P. in Soap Solution
64	Hydrocortisone, B.P.....................	—
65	Hydrocortisone Acetate, B.P.........	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. Hydrocortisone Acetate B.P. with Gramicidin, Neomycin Sulphate B.P., Thonzonium Bromide and Thonzylamine Hydrochloride
66	Idoxuridine..................................	—
67	Ipecacuanha, B.P..........................	Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
68	Isoprenaline Hydrochloride...........	—
69	Kanamycin Sulphate, B.P.C..........	—
70	Levallorphan Tartrate, B.P............	Levallorphan Tartrate B.P., with Pethidine Hydrochloride B.P.
71	Lofenalac....................................	—
72	Magnesium Chloride....................	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
73	Mebhydrolin Napadisylate, B.P.C.	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
74	Meclozine Hydrochloride, B.P......	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
75	Mepyramine Maleate, B.P............	—
76	Methacycline...............................	—
77	Methdilazine Hydrochloride.........	—
78	Methenamine Mandelate...............	—
79	Methyl Glucamine........................	Theophylline B.P. with Methyl Glucamine

80	Minafen.......................................	—
81	Morphine Tartrate........................	Morphine Tartrate with Tacrine
82	Naphazoline Nitrate, B.P..............	Naphazoline Nitrate B.P. with Antazoline Sulphate
83	Neomycin Sulphate, B.P...............	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. Neomycin Sulphate B.P. with Kaolin B.P. Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
84	Neostigmine Methylsulphate, B P	—
85	Nicotinamide, B.P........................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
86	Nitrofurantoin, B.P.......................	—
87	Nortriptyline Hydrochloride, B.P.	—
88	Nystatin, B.P................................	Tetracycline with a buffering agent and Nystatin B.P. Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P. Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
89	Nutramigen..................................	—
90	Oxytetracycline Hydrochloride, B.P.................................................	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
91	Oxytocin.....................................	Oxytocin with Ergometrine Maleate
92	Pancreatin Enzyme, U.S.N.F. XI...	—
93	Papaveretum, B.P.C.....................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
94	Penicillin, Benethamine, B.P.C.....	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
95	Penicillin, Benzathine, B.P............	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
96	Penicillin, Benzyl, B.P..................	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P. Fortified Procaine Penicillin Injection B.P. Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
97	Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid)......................	—
98	Penicillin, Potassium, B.P.............	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
99	Penicillin, Procaine, B.P...............	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. Fortified Procaine Penicillin Injection B.P. Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P. Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
100	Penicillin, Sodium, B.P.................	Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
101	Pertussis Vaccine, B.P..................	Diphtheria, Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P.

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
102	Pethidine Hydrochloride, B.P........	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P. Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
103	Phenethicillin Potassium, B.P........	—
104	Pheniramine Maleate....................	—
105	Phenytoin....................................	—
106	Pilocarpine Hydrochloride............	—
107	Pipenzolate Methobromide...........	—
108	Pituitary (Posterior Lobe), Powdered, B.P.C.......................................	—
109	Polymyxin B. Sulphate, B.P..........	Chloramphenicol B,P. with Polymyxin B. Sulphate B.P. Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic Acid
110	Polyvinyl Alcohol........................	—
111	Methylprednisolone, B.P..............	—
112	Prednisolone Sodium Hemisuccinate................................................	—
113	Prednisolone Sodium Phosphate, B.P.................................................	—
114	Prednisolone Trimethylacetate, B.P.	—
115	Primidone, B.P.............................	—
116	Promethazine Hydrochloride, B.P.	—
117	Riboflavine, B.P...........................	Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
118	Senna Fruit, B.P...........................	—
119	Silver Nitrate, Toughened, B.P......	—
120	Sobee..........................................	—
121	Sodium Aminosalicylate B.P.........	Sodium Aminosalicylate B.P. with Isoniazid B.P.
122	Sodium Lactate............................	Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P. Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P. Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P. Sodium Lactate with Sodium Chloride B.P. Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
123	Sodium Potassium Tartrate, B.P.C.	Compound Effervescent Powder B.P.C.
124	Sodium Tauroglycocholate, B.P.C. 1954........................................	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
125	Spearmint Oil, B.P.C....................	Terric with Spearmint Oil B.P.C. and Cetrimide B.P.
126	Strychnine, B.P.C. 1959...............	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha
127	Sulphacetamide, B.P.C.................	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
128	Sulphafurazole, B.P......................	—
129	Sulphamerazine, B.P. 1958...........	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C. Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C. Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
130	Sulphamethoxazole......................	—
131	Sulphaphenazole, B.P.C................	—
132	Sulphathiazole, B.P.C...................	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
133	Surgical Cement...........................	—
134	Surgical Cement Solvent..............	—
135	Tacrine........................................	Morphine Sulphate B.P. with Tacrine Morphine Tartrate with Tacrine
136	Terric...........................................	Hexachlorophane B.P. with Terric Terric with Spearmint Oil and Cetrimide B.P.
137	Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P...........................................	Diphtheria and Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P. Diphtheria, Tetanus and Pertussis Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.
138	Tetracycline.................................	Tetracyline with a buffering agent Tetracycline with a buffering agent and Amphotericin B. Tetracycline with a buffering agent and Nystatin B.P.
139	Thioridazine................................	—
140	Thonzonium Bromide...................	Thonzonium Bromide with Neomycin Sulphate B.P., Gramicidin, Thonzylamine Hydrochloride and Hydrocortisone Acetate B.P.
141	Thonzylamine Hydrochloride........	Thonzylamine Hydrochloride, Thonzonium Bromide, Neomycin Sulphate B.P., Gramicidin, Thonzonium Bromide and Hydrocortisone Acetate B.P.
142	Tragacanth, Indian (Gum Karaya)	—
143	Trifluoperazine Hydrochloride, B.P.	—
144	Triglyde.......................................	—
145	Trimeprazine Tartrate, B.P.C........	—
146	Triprolidine Hydrochloride, B.P.	—
147	Vasopressin.................................	—
148	Velactin.......................................	—
149	Viprynium Embonate, B.P............	—
150	Vitamin A....................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
151	Vitamin D....................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

THIRD SCHEDULE

Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

1.	Acetazolamide Sodium	65.	Calcium Phosphate, B.P.C.
2.	Acetohexamide	66.	Calumba, Concentrated Infusion, B.P. 1948
3.	Acetylcysteine	66.	Calumba, Concentrated Infusion, B.P. 1948
4.	Acetyl Sulphafurazole	67.	Calumba Tincture, B.P. 1948
5.	Acidified Golden Syrup, A.P.F. 1955	68.	Capsicum Ointment, B.P.C.
6.	Acriflavine, B.P.C.	69.	Capsicum Tincture, B.P.C.
7.	Acrylic Resin	70.	Carbamazepine
8.	Adrenaline Hydrochloride	71.	Carbenoxolone Sodium
9.	Adrenaline Mucate	72.	Carbinoxamine Maleate
10.	Agar, B.P.C. 1954	73.	Cardamom Aromatic Tincture, B.P.C.
11.	Aldosterone	74.	Catechu Tincture, B.P.C.
12.	Allopurinol	75.	Cephaloridine
13.	Aloin, B.P.C.	76.	Cetomacrogol Emulsifying Wax, B.P.C.
14.	Almond Oil Volatile Bitter, B.P.C. 1959	77.	Chloramine, B.P.C.
15.	Aluminium Acetate Solution, B.P.C.	78.	Chloramphenicol Palmitate, B.P.C.
16.	Aluminium Hydroxide Mixture, A.P.F.	79.	Chloramphenicol Stearate
17.	Aluminium Sodium Polphydroxy Monocarbonate Hexitol Complex	80.	Chloramphenicol Succinate
17.	Aluminium Sodium Polphydroxy Monocarbonate Hexitol Complex	81.	Chlorazanil Hydrochloride
18.	Aluminium Sodium Silicate	82.	Chlorhexidine Diacolate
19.	Aluminium Powder, B.P.C.	83.	Chlorhexidine Gluconate
20.	Amaranth Solution, A.P.F.	84.	Chlorobenzol Disulphonamide
21.	Amaranth Solution, Compound, A.P.F.	85.	Chlorotrianisene, B.P.C.
22.	Amaranth Solution, B.P.C.	86.	Chlorthalidone, B.P.C.
23.	Amino Acids	87.	Cholera El Tor Combined Vaccine
24.	Aminocaproic Acid	88.	Cinnamon Spirit, B.P.C. 1949
25.	Ammonia Aromatic Spirit, B.P.C.	89.	Cinnamon Water, Concentrated, B.P.C.
26.	Ammonia Solution Strong, B.P.C.	90.	Clemizole Hydrochloride
27.	Ammonium Bicarbonate, B.P.C.	91.	Clemizole Tanna te
28.	Ammonium Bromide, B.P.C.	92.	Clopamide
29.	Amphotericin B	93.	Clove, Concentrated Infusion, B.P.C. 1954
30.	Angiotensin Amide	93.	Clove, Concentrated Infusion, B.P.C. 1954
31.	Antazoline Methanesulphonate, B.P.C.	94.	Coal Tar, B.P.C.
32.	Antazoline Sulphate	95.	Cochineal Tincture, B.P. 1948
33.	Attapulgite	96.	Coconut Oil, B.P.C. 1949
34.	Azathioprine	97.	Codeine, B.P.C. 1954
35.	Beclamide	98.	Copper Sulphate, B.P.C.
36.	Beeswax, Yellow, B.P.C.	99.	Creosote, B.P.C. 1959
37.	Belladonna Suppository, B.P. 1948	100.	Cudbear Tincture, A.P.F. 1947
38.	Benedict’s Solution, A.P.F.	101.	Cyclopenthiazide
39.	Benzalkonium Chloride	102.	Cyclothiazide
40.	Benzoin, B.P.C.	103.	Cycrimine Hydrochloride
41.	Benzoin Compound Tincture, B.P.C.	104.	Cymogran
42.	Benzoin Tincture, B.P.C.	105.	Death Adder Antivenene
43.	Benzoinated Lard, B.P.C. 1954	106.	Demecarium Bromide
44.	Benzylpenicillin in Oil	107.	Deoxycortone Glucoside
45.	Bephenium Hydroxynaphthoate, B.P.C.	108,	Desferrioxamine
46.	Betamethasone Acetate	109.	Deslanoside
47.	Betamethasone Alcohol	110.	Dexamethasone Sodium Phosphate
48.	Betamethasone Phosphate	111.	Dexchlorpheniramine Maleate
49.	Bethanidine Sulphate	112.	Dextran
50.	Biperiden Hydrochloride	113.	Dextriferron
51.	Bismuth Subgallate, B.P.C.	114.	Dextromoramide Acid Tartrate
52.	Bretylium Tosylate	115.	Diazepam
53.	Brompheniramine Maleate	116.	Dihydroergotamine Methanesulphonate
54.	Brown Snake Antivenene	117.	Dihydromorphinone Hydrochloride, B.P.C. 1949
55.	Buchu Concentrated Infusion, B.P C. 1954	117.	Dihydromorphinone Hydrochloride, B.P.C. 1949
55.	Buchu Concentrated Infusion, B.P C. 1954	118.	Dihydrostreptomycin Sulphate, B.P. 1958
56.	Butabarbital Sodium	118.	Dihydrostreptomycin Sulphate, B.P. 1958
57.	Butyl Aminobenzoate, B.P 1953	119.	Dihydrotachysterol
58.	Cade Oil, B.P.C.	120.	Dimethicone, B.P.C.
59.	Caffeine and Sodium Benzoate, B P C 1954	121.	Dimethindene Maleate
59.	Caffeine and Sodium Benzoate, B P C 1954	122.	Diphenylpyraline Hydrochloride
60.	Caffeine Citrate, B.P.C. 1959	123.	Dipyridamole
61.	Cajuput Spirit, B.P. 1948	124.	Disodium Stilboestrol Diphosphate
62.	Calamine Cream Oily, A.P.F.	125.	Dithiazanine Iodide
63.	Calcium Di-Oxytetracycline	126.	Dyflos, B.P.C.
64.	Calcium Gluconogalactogluconate	127.	Ecothiopate Iodide

Third Schedule—continued

128.	Entsufon	192.	Isoprenaline Hydrochloride
129.	Ephedrine, B.P.C.	193.	Isopropramide Iodide
130.	Ergot, Liquid Extract, B.P. 1914	194.	Isothipendyl Hydrochloride, B.P.C.
131.	Erythrityl Tetranitrate	195.	Kanamycin Sulphate, B.P.C.
132.	Erythromycin Ethyl Succinate	196.	Kitasamycin
133.	Erythromycin Glucoheptonate	197.	Lanatoside-C.
134.	Erythromycin Lactobionate	198.	Lanette Wax SX
135.	Ethacrynic Acid	199.	Lavender Spike Oil, B.P.C.
136.	Ethanolamine, B.P.C.	200.	Lemon Tincture, B.P. 1958
137.	Ethanolamine Olcate	201.	Lincomycin Hydrochloride
138.	Ether Nitrous Spirit, B.P.C. 49 59	202.	Lipopancreatin
139.	Ethionamide	203.	Lobelia Ehercal Tincture, B.P.C.
140.	Ethoxzolamide	204.	Lofenalac
144.	Ethylidenc Discoumarin	205.	Lypressin
142.	Ethylnoradrenaline Hydrochloride	206.	Magenta, B.P.C.
143.	Ethyloestrenol	207.	Magnesium-Aluminium Hydroxide
144.	Eucalyptol, B.P.C.	208.	Magnesium Chloride
145.	Ferric Hydroxide	209.	Magnesium Hydroxide, B.P.C.
146.	Ferrous Aminoacetosulphate	210.	Mebhydrolin Napadisylate, B.P.C.
147.	Ferrous Carbonate Saccharated, B.P.C. 1959	211.	Medroxyprogesterone Acetate
147.	Ferrous Carbonate Saccharated, B.P.C. 1959	242.	Melphalan
148.	Ferrous Phosphate Compounds, Syrup B.P.C.	213.	Mopenzolate Bromide
148.	Ferrous Phosphate Compounds, Syrup B.P.C.	214.	Mercaptomerin Sodium
149.	Ferrous Succinate	215.	Mercuric Chloride, B.P.C.
150.	Fluorouracil Sodium	216.	Mestanolone
154.	Fluphenazine Hydrochloride	217.	Metaraminol Bitartrate
152.	Fluphenazine Oenanthate	218.	Metformin Hydrochloride
153.	Folinic Acid	249.	Methacycline
154.	Framycetin Sulphate	220.	Methaqualone Hydrochloride
155:	Frusemide	221.	Methazolamide
156.	Fusidic Acid, Diethanolamine Salt	222.	Methdilazine Hydrochloride
157.	Galactomin, Formula No. 11	223.	Methenamins Mandelate
158.	Galactomin, Formula No. 19	224.	Methenolone Acetate
159.	Gall and Opium Ointment, B.P.C.	225.	Methotrexate
160.	Gelsemium Tincture. B.P.C.	226.	Methoxamine Hydrochloride, B.P.C.
161.	Glucagon Hydrochloride	227.	Methsuximide
162.	Glucose Indicator	228.	Methyclothiazide
163.	Glycerophosphate Compound Syrup, A.P.F.	229.	Methyl Glucamine
163.	Glycerophosphate Compound Syrup, A.P.F.	230.	Methylphenobarbitone, B.P.C.
164.	Glyceryl Guaiacolate	231.	Methylprednisolone Acetate
165.	Glycopyrronium Bromide	232.	Metyrapone
166.	Glymidine	233.	Minafen
167.	Goats Milk, dehydrated	234.	Morphine Tartrate
168.	Gramicidin	235.	Myrrh Tincture, B.P.C.
169.	Hamamelis Liquid Extract, B.P.C.	236.	Nalidixic Acid
170.	Hetacillin	237.	Nandrolone Decanoate
171.	Hexocyclium Methylsulphate	238.	Natamycin
172.	Honey, Purified, B.P.C.	239.	Niclosamide
173.	Hydrargaphen	240.	Nicotinyl Alcohol Tartrate
174.	Hydrocyanic Acid, Dilute, B.P.C. 1954	241.	Nicoumalone
175.	Hydroxybenzoate Compound Powder. A.P.F.	242.	Nitromin
175.	Hydroxybenzoate Compound Powder. A.P.F.	243.	Nutramigen
176.	Hydroxyprogesterone	244.	Octatropine Methylbromide
177.	Hyoscine Methobromide	245.	Oestradiol Diproprionate, B.P.C. 1954
178.	Hypophosphorous Acid, Dilute, B.P.C	246.	Oestrone, B.P.C. 1954
179.	Idoxuridine	247.	Oily Ophthalmic Vehicle, A.P.F. 1955
180.	Indomethacin	248.	Orange Peel Compound, Concentrated Infusion, B.P.C. 1954
181.	Insulin Injection, specially purified	248.	Orange Peel Compound, Concentrated Infusion, B.P.C. 1954
182.	Insulin Injection, Biphasic	249.	Orange Peel, Concentrated Infusion, B.P.C.
183.	Insulin Injection, Neutral	249.	Orange Peel, Concentrated Infusion, B.P.C.
184.	Insulin Isophane Injection, specially purified	250.	Orciprenaline Sulphate
184.	Insulin Isophane Injection, specially purified	254.	Orphenadrine Hydrochloride
185.	Insulin Injection, Special P (pjg)	252.	Oxycodone Pectinate
186.	Iodochlorhydroxyquinoline	253.	Oxyinel, B.P.C.
187.	Iodoform, B.P.C. 4 954	254.	Oxyme of Squill, B.P.C.
188.	Iron Aminoates	255.	Oxymeslerone
189.	Iron Oxide Saccharated	256.	Oxyphenonium Bromide
190.	Iron Polymaltose Complex	257.	Oxytetracycline
191.	Iron Sorbitol Complex	258.	Oxytocin

Third Schedule—continued

259.	Pancreatin Enzyme, U.S.N.F. XI.	324.	Sobee
260.	Papaveretum, B.P.C.	325.	Sodium Edetate, B.P.C.
261.	Papuan Black Snake Antivenene	326.	Sodium Folate
262.	Para-Aminosalicylic Acid	327.	Sodium Lactate
263.	Paraben Ophthalmic Phosphate Buffer A.P.F. 1955	328.	Sodium Nitrite, B.P.C,
263.	Paraben Ophthalmic Phosphate Buffer A.P.F. 1955	329.	Sodium Potassium Tartrate, B.P.C.
264.	Paraben Ophthalmic Vehicle, A.F.F. 1955	330.	Sodium Tauroglycocholate, B.P.C. 1954
264.	Paraben Ophthalmic Vehicle, A.F.F. 1955	331.	Sodium Thiosulphate
265.	Paraffin Liquid Light, B.P.C.	332.	Spearmint Oil, B.P.C.
266.	Paramethasone Acetate	333.	Spiramycin
267.	Pargyline Hydrochloride	334.	Squill Tincture, B.P.C.
268.	Pectin	335.	Stanolone
269.	d-Penicillamine Hydrochloride, B.P.C.	336.	Stanozolol
270.	Penicillinase	337.	Stearic Acid, B.P.C.
271.	Penicillin Benethamine, B.P.C.	338.	Storax, Prepared, B.P.C.
272.	Pentaerythritol Tetranitrate, diluted, B.P.C.	339.	Strophanthus Tincture, B.P. 1948
272.	Pentaerythritol Tetranitrate, diluted, B.P.C.	340.	Strychnine, B.P.C. 1959
273.	Penthienate Methobromide	341.	Sulphacetamide, B.P.C.
274.	Peru Balsam, B.P.C.	342.	Sulphadiazine Sodium, B.P.C.
275.	Phenazone, B.P.C.	343.	Sulphaguanidine, B.P.C.
276.	Phenazopyridine Hydrochloride	344.	Sulphamerazine, B.P. 1958
277.	Phenformin Hydrochloride	345.	Sulphamethoxazole
278.	Pheniramine Maleate	346.	Sulphaphenazole, B.P.C.
279.	Pheniramine Para-Aminosalicylate	347.	Sulphasalazine
280.	Phenol Ointment, B.P. 1948	348.	Sulphathiazole, B.P.C.
281.	Phenoxymethylpenicillin, Benzathine	349.	Sulphomyxin Sodium
282.	Phenoxymethylpenicillin, Hydrabamine	350.	Sulphurated Potash, B.P.C.
283.	Phensuximide	351.	Sulphuric Acid, Dilute, B.P.C.
284.	Phenthimentonium	352.	Sulphur Sublimed, B.P.C.
285.	Phenytoin	353.	Sultiame
286.	Phthalylsulphacetamide	354.	Surgical Cement
287.	Physotiomine, B.P.C.	355.	Surgical Cement Solvent
288.	Pilocarpine Hydrochloride	356.	Sustanon
289.	Pipenzolate Methobromide	357.	Syrup Glucose Liquid, B.P.C.
290.	Pituitary Hormone, Follicle-stimulating, Human	358.	Tacrine
290.	Pituitary Hormone, Follicle-stimulating, Human	359.	Taipan Antivenene
291.	Pituitary Hormone, Growth, Human	360.	Tar Ointment, B.P.C. 1959
292.	Pituitary (Posterior Lobe) Powdered, B.P.C.	361.	Tartrazine, B.P.C. 1954
292.	Pituitary (Posterior Lobe) Powdered, B.P.C.	362.	Terric
293.	Polyoestradiol Phosphate	363.	Testosterone Oenanthate
294.	Polyvinyl Alcohol	364.	Tetanus Immune Globulin (Human)
295.	Polythiazide	365.	Tetracosactide
296.	Potable Water	366.	Tetracycline
297.	Potassium: Chlorate, B.P.C.	367.	Theophylline Ethanoate of Piperazine
298.	Potassium Effervescent Tablets	368.	Thiethylperazine
299.	Prednisolone Sodium Hemisuccinate	369.	Thioridazine
300.	Prednisolone Sodium Hemisulphate	371.	Thonzonium Bromide
301.	Prednisolone Tertiary Butyl Acetate	372.	Thonzylamine Hydrochloride
302.	Procarbazine Hydrochloride	373.	Thyrotrophin
303.	Propranolol Hydrochloride	374.	Tiger Snake Antivenene
304.	Protoveratrine A	375.	Titanium Dioxide, B.P.C.
305.	Pumilio Pine Oil, B.P.C.	376.	Tolu Tincture, B.P.C. 1959
306.	Pyrazinamide	377.	Tragacanth, Indian (Gum Karaya)
307.	Pyridine Aldoxime Methiodide	378.	Trasylol
308.	Quillaia Tincture, B.P.C.	379.	Tretamine
309.	Quinethazone	380.	Triamterene
310.	Quinidine Bisulphate	381.	Tridihexethyl Chloride
311.	Raspberry Syrup, B.P.C.	382.	Triethanolamine, B.P.C.
312.	Rauwolfia Alkaloids	383.	Triglyde
313.	Red Back Spider Antivenene	384.	Trimeprazine Tartrate, B.P.C.
314.	Rolitetracycline	385.	Trolnitrate Phosphate
315.	Rosemary Oil, B.P.C.	386.	Vadrine
316.	Salicylamide	387.	Valerian Ammoniated Tincture, B.P.C.
317.	Senega, Concentrated Infusion, B.P.C.	388.	Vanillin
318.	Senna Compound Mixture, B.P.C. 1959	389.	Vasopressin Tannate
319.	Senna, Concentrated Infusion, B.P.C. 1959	390.	Velactin
319.	Senna, Concentrated Infusion, B.P.C. 1959	391.	Vinblastine Sulphate
320.	Senna Fruit Extract (Standardised)	392.	Vincristine Sulphate
321.	Siberian Fir Oil, B.P.C. 1949	393.	Vinegar of Squill, B.P.C.
322.	Silver Protein, B.P.C.	394.	Vitamin A
323.	Silver Protein Mild, B.P.C.	395.	Vitamin D

FOURTH SCHEDULE

Regulation 12.

Additives

1.	Acetone, B.P.C.	13.	Dilute Alcohols, B.P.
2.	Alcohol (95%), B.P.	14.	Ether Anaesthetic, B.P.
3.	Arachis Oil, B.P.	15.	Honey—Purified
4,	Amethocaine Hydrochloride, B.P.	16.	Maize Oil, B.P.
5.	Camphor, B.P.	17.	Olive Oil, B.P.
6.	Caraway Oil, B.P.C.	18.	Pilocarpine Hydrochloride
7.	Carmine Solution, A.P.F.	19.	Saccharin Sodium, B.P.
8.	Citronella Oil, B.P.C.	20.	Sodium Thiosulphate, B.P.C.
9.	Chloroform, B.P.	21.	Solution of Burnt Sugar, B.P.C. 1959
10.	Cottonseed Oil, B.P.	22.	Spirit, Methylated, Industrial
11.	Dextrose, B.P.	23.	Xylene, B.P.C. 1949
12.	Dextrose Monohydrate, B.P.

FIFTH SCHEDULE

Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
1	Acetylcysteine...............................	Fibrocystic Disease
2	Acetylsalicylic Acid Tablets, B.P.
3	Soluble Acetylsalicylic Acid Tablets B.P...................................................	Any disease or condition in a pensioner

4	Acetylaslicylic Acid with Paracetamol and Caffeine Tablets
5	Acrylic Resin................................	Ileostomy or colostomy conditions
6	Aldosterone..................................	With the written authority of the Director-General, treatment of an acute crisis in— Addison’s disease Salt-losing congenital adrenal hypoplasia
7	Allopurinol...................................	Chronic gout not responding to other pharmaceutical benefits
8	Aminocaproic Acid.......................	Any disease or condition in a patient receiving treatment
9	Amino Acids.................................	in or at an approved hospital
10	Amitriptyline Tablets, B.P..............	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
11	Amphetamine Sulphate Tablets, B.P.	Any disease or condition in a pensioner
12	Amphotericin B.............................	Systemic fungal infection

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
With the written authority of the Director-General—Gram-negative infections in pregnant women
13	Ampicillin Capsules, B.P...............	Infections, in children under the age of live years, in which penicillin and sulphonamides are not effective.
14	Ampicillin Injections, Tablets and Suspension................................
Infections where positive bacteriological evidence confirms that ampicillin is the only appropriate therapeutic agent
15	Aneurine Hydrochloride Tablets B.P.	Any disease or condition in a pensioner
16	Angiotensin Amide........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
17	Ascorbic Acid Tablets, B.P............	Any disease or condition in a pensioner
18	Azathioprine.................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
19	Beclamide.....................................
20	Benzoin Compound Tincture, B.P.C.	Ileostomy and Colostomy conditions
21	Betamethasone Tablets..................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
22	Betamethasone Acetate and Betamethasone Alcohol Injection	Intra-articular use
23	Betamethasone Sodium Phosphate Injection, B.P.............................	Intra-articular use
24	Busulphan Tablets, B.P..................	Treatment in neoplastic disease
Any disease or condition in a pensioner
25	Calciferol Tablets, B.P...................	With the written authority of the Director-General—Hypoparathyroidism
26	Calciferol, B.P...............................	Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
27	Calcium Aminosalicylate...............	Tuberculosis
28	Calcium Gluconogalactogluconate Effervescent Tablets...................	Hypoparathyroidism
29	Carbamazepine..............................	Epilepsy Trigeminal neuralgia
30	Carbenoxolone Sodium..................	Any disease or condition in a patient receiving treatment in or at an approved hospital
31	Cephaloridine................................
32	Chlorambucil Tablets, B.P.............	Treatment in neoplastic disease
33	Chloramine Deodorant Tablets and Powder......................................	Ileostomy or colostomy conditions
34	Chloramphenicol Capsules, B.P......	Bacterial meningitis
Haemophilus influenzae infections
Intra-ocular infections
Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol
35	Chloramphenicol Injections............	A disease or condition specified in this column in relation to Chloramphenicol Capsules
36	Chloramphenicol Tablets...............
37	Chloramphenicol Oral Suspension
38	Chlorotrianisene Tablets................	Carcinoma of the prostate
39	Chlorpromazine Hydrochloride......	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General— Late-stage malignancy Radiation sickness Huntington’s chorea

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
39	Chlorpromazine Hydrochloride—continued	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
40	Chlortetracycline Capsules B.P.	Brucellosis Herpes zoster ophthalmicus Intestinal amoebiasis Leptospirosis Lymphogranuloma venereum Psittacosis Rickettsial infections Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
41	Chlortetracycline Hydrochloride Granules	A disease or condition specified in this column in relation to Chlortetracycline Capsules
42	Cloxacillin Sodium, B.P.................	Any disease or condition in a patient receiving treatment
43	Cloxacillin Capsules, B.P...............	in or at an approved hospital
44	Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets
45	Codeine Phosphate with Acetylsalicylic Acid Tablets
46	Codeine Phosphate with Acetylsalicylic Acid and Paracetamol soluble Tablets	Any disease or condition in a pensioner
47	Codeine Phosphate with Acetylsalicylic Acid, Paracetamol and Caffeine Tablets
48	Cod Liver Oil Emulsion.................	Any disease or condition in a child under the age of twelve years or in a pensioner
49	Colistin Sulphomethate Injection, B.P.	Pyocyaneus infection and Gram-negative infections where no other drug is effective
50	Corticotrophin Injection, B.P.	With the written authority of the Director-General—
51	Corticotrophin Gelatin Injection, B.P.	A disease or condition specified in this column in relation to Cortisone Injection
52	Corticotrophin Zinc Hydroxide Injection, B.P.	Hypsarrhythmia Salaam convulsions The prevention of side effects of corticosteroid therapy
53	Cortisone Injection, B.P.................	With the written authority of the Director-General— Acute exophthalmic ophthalmoplegia Acute heart block complicating myocardial infarction Anaemia, acquired haemolytic Addison’s disease Adrenocortical hypoplasia Adrenalectomy, total Adrenogenital syndrome

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
53	Cortisone Injection, B.P.—continued	Agranulocytosis Behcet’s syndrome Benign intracranial hypertension Cerebral tumours and cerebral oedema Cranial arteritis Cushing’s syndrome, including hyperadrenocorticalism Dermatitis, acute exfoliative Dermatomyositis Encephalitis Encephalomyelitis Encephalomyelitis, acute disseminated Guillain-Barré syndrome Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis Hansen’s disease Hepatitis, progressive or continuing, proven by biopsy or biochemistry Hodgkin’s disease Idiopathic hypercalcaemia Inflammatory conditions of the uveal tract and retina Interstitial Keratitis due to syphilis or vernal conjunctivitis Keratoplasty Leucine-sensitive hypoglycaemia Leukaemia Lymphosarcoma and follicular lymphoma Meningitis Metastatic breast cancer Mycosis fungoides Nephrosis or nephrotic syndrome Neuromyelitis optica Oedema of the spinal cord following trauma or infection Opticneuritis following removal of tumor of the brain Panhypopituitarism Pemphigus Periarteritis nodosa Progressive transverse myelitis Pseudohermaphroditism Purpura, Henoch’s Purpura, thrombocytopenic Red cell aplasia Regional ileitis (Crohn’s disease) Reticulum cell sarcoma Rheumatic carditis, acute Sarcoidosis Scleroderma Severe reactions of the skin and mucosa following X-ray therapy Splenic neutropenia Status asthmaticus Steroid therapy prior to operation in patients under steroid therapy Stevens-Johnson syndrome Still’s disease in a child under the age of sixteen years Sympathetic ophthalmitis Systemic lupus erythematosus Temporal arteritis Treatment of malignancy in conjunction with radiotherapy or chemotherapy Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
53	Cortisone Injection, B.P.—continued	Typo II Nephritis
Ulcerative colitis proven by sigmoidscopy or radiological report	Cortisone Injection, B.P.—continued
54	Cortisone Tablets, B.P...................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
55	Cyanocobalamin Injection, B.P.	Established megalocytic anaemia Neuroblastoma Subacute combined degeneration of the cord Treatment in post-gastrectomy
56	Cymogran.....................................	With the written authority of the Director-General, phenylketonuria
57	Cycloserine Tablets, B.P................	Any disease or condition in a patient receiving treatment in or at an approved hospital
58	Cycloserine Capsules, B.P..............
59	Demethylchlortetracycline Capsules, B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
60	Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension
61	Demethylchlortetracycline Hydrochloride with Nystatin	Any disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin
62	Deodorant Detergent Solution (Terric with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
63	Deoxycortone Aqueous Injections	Addison’s disease Adrenalectomy, total
64	Deoxycortone Acetate Injection, B.P.
65	Deoxycortone Trimethylacetate Injection, B.P.
66	Deoxycortone Acetate Implants, B.P.
67	Deoxycortone Acetate Tablets
68	Desferrioxamine............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
69	Dexamethasone Tablets, B.P.	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
70	Dexamethasone Sodium Phosphate Injections	Intra-articular use
71	Dexamphetamine Tablets, B.P.	Any disease or condition in a pensioner
72	Dextromoramide Tablets................	Treatment in neoplastic disease
73	Dextromoramide Injection.............	Treatment in neoplastic disease
74	Diazepam Injection, Syrup and 10 mg. tablet	Epilepsy
75	Diazepam Tablets 2 mg. and 5 mg.	Epilepsy Treatment in multiple sclerosis
76	Dienoestrol Cream.........................	Any disease or condition in a pensioner
77	Dienoestrol Tablets, B.P................	Carsinoma of the prostate Mammary carcinoma Any disease or condition in a pensioner
78	Dihydrotachysterol	Parathyroid deficiency
79	Diloxanide Furoate Tablets, B.P.	Amoebic dysentery
80	Dimethicone.................................	Ileostomy or colostomy conditions
81	Disodium Stilboestrol Diphosphate	Carcinoma of the prostate

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
82	Dithiazanine Iodide.......................	Infestations of Trichuris trichiura or Strongyloides stercoralis
83	Ditophal........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
84	Erythromycin................................	Brucellosis Intestinal amoebiasis Leptospirosis Lymphogranuloma venereum Mycoplasma pneumoniae (Eaton’s Agent) Psittacosis Rickettsial infections Staphylococcal septicaemia or staphylococcal pneumonia Any bacterial infections or spirochaetal infection or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
85	Ethinyloestradiol Tablets, B.P.	Any disease or condition in a pensioner Hereditary telangiectasis Pre-menopausal castration syndrome Turner’s syndrome
86	Ethionamide..................................	Tuberculosis
87	Ethisterone Tablets, B.P.................	Turner’s syndrome
88	Ethyloestrenol...............................	With the written authority of the Director-General, intermittent use for corticosteriod-induced osteoporosis Intermittent use for patients on long term treatment with corticosteroids
89	Fludrocortisone Tablets, B.P.	Addison’s disease Adrenocortical hypoplasia Total adrenalectomy
90	Fluorouracil Sodium......................	Treatment in neoplastic disease
91	Fluoxymesterone Tablets, B.P........	Castration syndrome (male) Mammary carcinoma With the written authority of the Director-General; intermittent use for corticosteroid-induced osteoporosis
92	Fluphenazine Oenanthate Injection	A disease or condition specified in this column in relation to Chlorpromazine Hydrochloride
93	Fluphenazine Hydrochloride Elixir
94	Fluphenazine Hydrochloride Tablets and Injection
95	Folic Acid Injection.......................	Marcrocytic anaemia
96	Folic Acid Tablets, B.P..................	Sprue or the sprue-like syndrome
97	Folonic Acid.................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
98	Framycetin Sulphate Tablets	Bowel sterilization preparatory to major surgery
99	Fusidic Acid (Sodium Salt or Diethanolamine Salt)	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic
100	Galactomin Formula No. 11	With the written authority of the Director-General—Galactosaemia Conditions needing an extreme restriction of lactose in the patient’s diet, in children under the age of four years
101	Galactomin Formula No. 19	With the written authority of the Director-General—Glucose-galactose malabsorption

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
102	Goats Milk, dehydrated..................	With the written authority of the Director-General; cows milk allergy in children under the age of four years
103	Griseofulvin Tablets, B.P...............	With the written authority of the Director-General; for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination
104	Halibut Liver Oil Capsules.............	Any disease or condition in a pensioner
105	Hetacillin Capsules........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
106	Hexachlorophane with Entsufon
107	Hexachlorophane with Lissapol	Any disease or condition in a patient receiving treatment in or at an approved hospital
108	Hexachlorophane in Soap Solution
109	Hydrocortisone Injection................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
110	Hydrocortisone Acetate Injection, B.P.	Intra-articular use
111	Hydrocortisone Sodium Succinate Injection	Acute adrenal failure due to medical or surgical crisis Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy Stevens-Johnson syndrome
112	Hydroxocobalamin Injection, B.P.	Established megalocytic anaemia Neuroblastoma Sub-acute combined degeneration of the cord Treatment in post-gastrectomy
113	Hydroxyprogesterone....................	Endometrial carcinoma Habitual abortion Progesterone deficiency proven by hormonal assay of lateral wall smear
114	Idoxuridine...................................	Infections caused by Herpes Simplex Virus
115	Imipramine Tablets, B.P................	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require, further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortiriptyline Hydrochloride
116	Indomethacin Capsule...................	Rheumatoid arthritis or osteoarthritis not responding to salicylates Acute attacks of gout Ankylosing spondylitis Psoriatic arthritis Reiter’s syndrome
117	Isoniazid Tablets, B.P....................	Tuberculosis
118	Kanamycin Sulphate Capsules, Injections and Oral Solution	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antiboitic

119

Kitasamycin..................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
120	Levorphanol Tartrate.....................	Obstetrical use Severe intractable pain
121	Lincomycin Hydrochloride............	Osteomyelitis Pneumococcal Meningitis
122	Liothyronine Tablets, B.P..............	Myxoedema Myxoedema coma
123	Lipopancreatin..............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
124	Lofenalac......................................	With the written authority of the Director-General, phenylketonuria
125	Medroxyprogesterone Acetate Tablets	Endometrial carcinoma
126	Medroxyprogesterone Acetate Injections	Endometrial carcinoma Progesterone deficiency proven by hormonal assay of lateral wall smear
127	Melphalan.....................................	Treatment in neoplastic disease
128	Mercaptopurine Tablets, B.P..........	Allergic angiitis Treatment in neoplastic disease Lupus erythematosus Nephrosis or Nephrotic syndrome Periarteritis
129	Mestanolone.................................	Mammary carcinoma With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis Intermittent use for patients on long-term treatment with cortico steroids
130	Methacycline................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
131	Methandienone Tablets, B.P...........	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
132	Methenolone Acetate.....................	Intermittent use for patients on long-term treatment with corticosteroids
133	Methicillin Sodium........................	Any disease or condition in a patient receiving treatment
134	Methicillin Injection, B.P...............	in or at an approved hospital
135	Methotrexate Tablets.....................	Treatment in neoplastic disease
136	Methotrexate Injections.................	Any disease or condition in a patient receiving treatment in or at an approved hospital
137	Methylamphetamine Injection, B.P.	Any disease or condition in a pensioner
138	Methylamphetamine Tablets, B.P.	Any disease or condition in a pensioner
139	Metyrapone...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
140	Minafen........................................	With the written authority of the Director-General, phenylketonuria
141	Morphine Sulphate, B.P. with Tacrine Tablets......................................	Severe intractable pain
142	Mustine Hydrochloride Injection	Treatment in neoplastic disease
143	Nalidixic Acid...............................	With the written authority of the Director-General, urinary tract infections
144	Nandrolone Phenylpropionate Injection, B.P............................................	With the written authority of the Director-General, intermittent use for corticosteriod-induced osteoporosis
145	Nandrolone Decanoate...................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis Intermittent use for patients on long-term treatment with corticosteroids

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
146	Neomycin Sulphate, B.P. with Gramicidin, Thonzomium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate, B.P.	Any disease or condition in a pensioner
147	Neomycin Tablets, B.P..................	Bowel sterilization preparatory to major surgery Portal-systematic encephalopathy
148	Nicotinic Acid Tablets, B.P............	Any disease or condition in a pensioner
149	Nitrofurantoin Tablets, B.P.	Urinary tract infections
150	Nitrofurantoin Oral Suspension	Urinary tract infections
151	Nitromin.......................................	Treatment in neoplastic disease
Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
152	Nortriptyline Hydrochloride, B.P.	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
153	Nortriptyline Tablets, B.P..............	The treatment of a mental disorder in a person who has,
154	Nortriptyline Capsules, B.P............	after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitryptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
155	Nutramigen...................................	With the written authority of the Director-General— Cows milk allergy in children under the age of four years Galactosaemia Lactose intolerance Fibrosystic disease of the pancreas
156	Nystatin Tablets, B.P.....................	Monilia infections
157	Orciprenaline Sulphate Injection	Any disease or condition in a patient receiving treatment in or at any approved hospital
158	Orciprenaline Sulphate Solution for Inhalation
159	Oxycodone Pectinate.....................	Late-stage malignancy
160	Oxymesterone...............................	With the written authority of the Director-General; intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long term treatment with corticosteroids
161	Oxytetracycline Hydrochloride Capsules	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
162	Oxytetracycline Tablets, B.P.
163	Oxytetracycline Injections..............
164	Calcium di-Oxytetracycline Oral Suspension
165	Calcium di-Oxytetracycline Paediatric Drops
166	Oxytetracycline Hydrochloride with a buffering agent and Nystatin	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
167	Pancreatin, B.P..............................	Fibrocystic disease
168	Pancreatin Enzyme U.S.N.F. XI	Pancreatico-duodenectomy Pancreatic steatorrhoea
169	Para-Aminosalicylic Acid..............	Tuberculosis
170	Paracetamol Suspension.................	Any disease or condition in a pensioner
171	Paracetamol Tablets, B.P...............	Any disease or condition in a pensioner
172	Paracetamol with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
173	Paramethasone Acetate..................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
174	Paraffin Liquid Emulsion...............	Any disease or condition in a pensioner
175	Paraffin Liquid Emulsion with Phenolphthalein	Any disease or condition in a pensioner
176	Pargyline Hydrochloride................	Any disease or condition in a patient receiving treatment in or at an approved hospital
177	Penicillamine................................	With the written Authority of the Director-General—
Cystinisis Cystinuria with calculus formation Treatment of cold agglutinin haemoglobinuria Acute heavy metal intoxication Wilson’s Disease (hepatolenticular degeneration)
178	Penicillin Benzathine Tablets and Capsules	Prevention of recurrent streptococcal infections, including rheumatic fever
179	Penicillin Benzyl Tablets, B.P.
180	Penicillin Benzyl Capsules.............
181	Benzylpenicillin injection 5.000,000 units and 10.000,000 units	Bacterial endocarditis or septicaemia
182	Benzylpenicillin with Streptomycin Sulphate	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
183	Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate
184	Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use
185	Phenylbutazone Tablets, B.P.	Rheumatoid arthritis or osteoarthritis not responding to salicylates Acute attacks of gout Ankylosing spondylitis Psoriatic arthritis Reiter’s syndrome
186	Phenylbutazone Capsules...............
187	Phytomenadione Injection, B.P.	Antidote to anticoagulants
188	Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
189	Polymyxin B. Sulphate Injection	Any disease or condition in a patient receiving treatment in or at an approved hospital
190	Polyocstradiol Phosphate...............	Carcinoma of the prostate
191	Prednisolone Sodium Phosphate Retention Enema and Suppository	With the written authority of the Director-General— Ulcerative colitis proven by sigmoidoscopy or radiological report Proctitis proven by sigmoidoscopy
192	Prednisolone Tablets, B.P..............	With the written authority of the Director-General— Cerebral oedema; Cerebral tumors; Acute exophthalmic ophthalmoplegia; Interstitial keratitis due to syphilis or vernal conjunctivitis; Malignancy treatment in conjunction with radiotherapy or chemotherapy; Acute heart block complicating myocardial infarction; Benign intracranial hypertension; Encephalatis; Malignant exopthhalmos;

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Meningitis; Nodular non-suppurative panniculitis (Christian-Weber disease); Oedema of the spinal cord following trauma or infection; A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy or Addison’s disease or andrenocortical hypoplasia
193	Prednisolone Methyl Acetate Injections	Intra-articular use Retrobulbar injection in posterior uveitis
194	Prednisolone Acetate Injection
195	Prednisolone Tertiary Butyl Acetate Injections	Intra-articular use
196	Prednisolone Trimethylacetate Injections
197	Methylprednisolone Tablets, B.P.	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
198	Methylprednisolone Capsules
199	Prednisolone Sodium Hemisuccinate	Acute adrenal failure due to medical or surgical crisis Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy Stevens-Johnson syndrome
200	Prednisone Tablets, B.P.................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
201	Procarbazine Hydrochloride...........	Treatment in neoplastic disease
202	Progesterone.................................	Habitual abortion Progesterone deficiency proven by hormonal assay of lateral wall smear
203	Propranolol Hydrochloride.............	Any disease or condition in a patient receiving treatment in or at an approved hospital
204	Pyrazinamide................................
205	Pyridostigmine Injection, B.P.	Myasthenia gravis
206	Pyridostigmine Tablets, B.P.	Myasthenia gravis
207	Pyridoxine Hydrochloride	Peripheral neuritis due to isoniazid therapy
Tablets	Radiation sickness
208	Pyrimethamine Tablets..................	Treatment of toxoplasmosis
209	Quinine Bisulphate Tablets, B.P.	Dystrophia myotonica
210	Quinine Dihydrochloride Tablets	Malaria Myotonia atrophica
211	Quinine Hydrochloride Tablets	Myotonia congenita Any disease or condition in a pensioner
212	Quinine Sulphate Tablets, B.P.
213	Riboflavine Tablets.......................	Any disease or condition in a pensioner
214	Senna Fruit Extract (Standardised)	Any disease or condition in a pensioner
215	Sobee............................................	With the written authority of the Director-General— Galactosaemia Homocystinuria Lactose intolerance Milk allergy in children under the age of four years
216	Sodium Aminosalicylate Tablets, B.P.
217	Sodium Aminosalicylate Injection
218	Sodium Aminosalicylate Cachets	Tuberculosis
219	Sodium Aminosalicylate Granules
220	Sodium Aminosalicylate with Isoniazid, B.P.

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
221	Sodium Folate...............................	Macrocytic anaemia
Sprue or the sprue-like syndrome
222	Spiramycin...................................	Serologically proven active toxoplasmosis
Staphylococcal septicaemia or staphyloccocal pneumonia
Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins
223	Spironolactone Tablets, B.P.	With the written authority of the Director-General: to supplement other diuretics when these have proved inadequate
Myasthenia Gravis
224	Stanolone......................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
225	Stanozolol.....................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
226	Stilboestrol Injection......................	Carcinoma of the prostate Mammary carcinoma Any disease or condition in a pensioner Heriditary Telengiectasis
227	Stilboestrol Tablets, B.P.................
228	Streptomycin Sulphate Injections		Bacillary dysentery that is resistant to the Sulphonamides Brucellosis Chancroid Endocarditis due to Streptococcus faecalis or Streptococcus viridans Friedlander bacillus infections Haemophilus influenzae infections Plague Pseudomonas pyocyanea infections Rat-bite fever (Streptobacillus moniliformis) Salmonella infections Surgical conditions of the bowel (pre-operative and postoperative) Surgical conditions of the thoracic organs Tuberculosis Tularaemia Urinary tract infections that are resistant to the Sulphonamides
229	Sulphasalazine..............................		Ulcerative colitis
230	Sulphomyxin Sodium....................	Any disease or condition in a patient receiving treatment in or at an approved hospital
231	Sultiame........................................	For use where other anticonvulsants have failed
232	Surgical Cement............................	Ileostomy or colostomy conditions
233	Surgical Cement Solvent................	Ileostomy or colostomy conditions
234	Sustanon.......................................	Castration syndrome (male) Klinfelter Reifenstein Albright syndrome Mammary carcinoma
235	Testosterone Implants, B.P.............
236	Testosterone Oenanthate................
237	Testosterone Proprionate Injection, B.P.
238	Methyltrestosterone Tablets, B.P.
239	Methyltestosterone, B.P.................

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
240	Tetanus Antitoxin, B.P. (Bovine)	Patients known to be sensitive to horse serum
241	Tetanus Immune Globulin (Human)	With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle serum
242	Tetracosactide...............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
243	Tetracycline Capsules, B.P.............	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
244	Tetracycline Tablets, B.P...............
245	Tetracycline Injections...................
246	Rolitetracycline.............................
247	Tetracycline Hydrochloride Granules, Paediatric Drops and Syrup
248	Tetracycline with a buffering agent
249	Tetracycline with a buffering agent and Amphotercin B	A disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin
250	Tetracycline with a buffering agent and Nystatin
251	Thiambutosine Tablets, B.P.	Hansen’s disease
252	Thiambutosine Injection................	Hansen’s disease
253	Thiethylperazine Tablets and Suppositories	With the written authority of the Director-General, Radiation sickness
254	Thioridazine Tablets, B.P...............	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General, Late-stage malignancy Radiation sickness With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
255	Thioridazine..................................
256	Thyrotrophin.................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
257	Tragacanth, Indian (Gum Karaya)	Ileostomy or colostomy conditions
258	Trasylol........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
259	Tretamine.....................................	Treatment in neoplastic disease

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
260	Trifluoperazine Tablets, B.P.	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General, Late-stage malignancy Radiation sickness With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
	261	Trifluoperazine Hydrochloride, B.P.
262	Triglyde........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
263	Trimetaphan Injection, B.P.............	Hypotensive for anaesthesia
264	Vadrine.........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
265	Vasopressin Nasal Spray................	Diabetes insipidus
266	Velactin........................................	With the written authority of the Director-General, Galactosaemia Homocystinuria Lactose intolerance Milk allergy in children under the age of four years
267	Vinblastine Sulphate......................	Treatment in neoplastic disease
268	Vincristine Sulphate......................	Treatment in neoplastic disease
269	Viomycin Sulphate........................	Tuberculosis
270	Viomycin Sulphate Injection, B.P.	Tuberculosis
271	Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner
272	Neomycin Sulphate Powder	With the written authority of the Director-General, Intermittent use by inhalation in fibrocystic disease

Amendments in relation to decimal currency.

4. The National Health (Pharmaceutical Benefits) Regulations are further amended as set out in the Schedule to these Regulations.

THE SCHEDULE

Regulation 4.

Amendments of the National Health (Pharmaceutical Benefits) Regulations

Provision amended—	Omit—	Insert—
Regulation 9..........................................	Fifty pounds	One hundred dollars
Regulation 17........................................	Twenty pounds	Forty dollars
Regulation 18a (3.)................................	Ten pounds	Twenty dollars
Regulation 22(3.)...................................	Ten pounds	Twenty dollars
Regulation 22(4.)...................................	Ten pounds	Twenty dollars
Regulation 28........................................	Ten pounds	Twenty dollars
Regulation 29(1.) (a)..............................	Two shillings and sixpence	Twenty-five cents
Regulation 29(1.) (b)..............................	Five shillings	Fifty cents
Regulation 31........................................	Ten pounds	Twenty dollars
Regulation 32(1.)...................................	Ten pounds	Twenty dollars
Regulation 33........................................	Ten pounds	Twenty dollars
Regulation 37........................................	Ten pounds	Twenty dollars

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra